Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 17, 2023

BUY
$11.0 - $21.45 $11,000 - $21,450
1,000 Added 4.67%
22,400 $265 Million
Q3 2022

May 16, 2023

SELL
$20.09 - $35.8 $14,063 - $25,059
-700 Reduced 3.17%
21,400 $449 Million
Q1 2022

Apr 21, 2022

SELL
$36.48 - $52.22 $102,143 - $146,216
-2,800 Reduced 11.24%
22,100 $907,000
Q4 2021

Feb 03, 2022

SELL
$33.11 - $55.01 $16,555 - $27,505
-500 Reduced 1.97%
24,900 $1.08 Million
Q3 2021

Oct 21, 2021

BUY
$50.07 - $66.05 $15,021 - $19,815
300 Added 1.2%
25,400 $1.27 Million
Q2 2021

Aug 13, 2021

BUY
$56.61 - $80.46 $220,779 - $313,794
3,900 Added 18.4%
25,100 $1.58 Million
Q1 2021

Apr 30, 2021

BUY
$86.23 - $125.19 $301,805 - $438,165
3,500 Added 19.77%
21,200 $1.97 Million
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $95,004 - $133,764
1,200 Added 7.27%
17,700 $1.59 Million
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $147,438 - $242,892
-1,800 Reduced 9.84%
16,500 $1.71 Million
Q2 2020

Aug 12, 2020

SELL
$54.33 - $89.52 $27,165 - $44,760
-500 Reduced 2.66%
18,300 $1.45 Million
Q1 2020

May 12, 2020

SELL
$49.34 - $68.76 $83,878 - $116,892
-1,700 Reduced 8.29%
18,800 $1.09 Million
Q4 2019

Jan 27, 2020

BUY
$51.21 - $59.06 $5,121 - $5,906
100 Added 0.49%
20,500 $1.11 Million
Q3 2019

Oct 22, 2019

BUY
$40.6 - $57.2 $20,300 - $28,600
500 Added 2.51%
20,400 $1.07 Million
Q2 2019

Jul 26, 2019

SELL
$39.92 - $53.86 $7,984 - $10,772
-200 Reduced 1.0%
19,900 $961,000
Q1 2019

Apr 25, 2019

BUY
$48.23 - $66.16 $159,159 - $218,328
3,300 Added 19.64%
20,100 $1.02 Million
Q4 2018

Feb 07, 2019

SELL
$55.63 - $73.24 $328,217 - $432,115
-5,900 Reduced 25.99%
16,800 $996,000
Q3 2018

Nov 02, 2018

SELL
$52.05 - $66.51 $119,715 - $152,973
-2,300 Reduced 9.2%
22,700 $1.49 Million
Q2 2018

Aug 03, 2018

BUY
$48.33 - $55.64 $1.21 Million - $1.39 Million
25,000 New
25,000 $1.26 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.